Hosted on MSN25m
Mineralys Therapeutics Receives FDA Clearance for Phase 2 Trial of Lorundrostat in Treating Sleep Apnea and HypertensionRADNOR, PA — Mineralys Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its ...
Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback